EMA
approval
· 2019-10-18
First non-injectable treatment for severe low blood sugar levels
Summary
EMA announces approval of the first non-injectable treatment for severe hypoglycemia, expanding options for management of severe low blood sugar levels.
Upgrade for the full analysis, importance score, and drug timeline.